Potential of Proapoptotic Peptides to Induce the Formation of Giant Plasma Membrane Vesicles with Lipid Domains

Chembiochem. 2015 Jun 15;16(9):1288-92. doi: 10.1002/cbic.201500045. Epub 2015 May 14.

Abstract

We have established a method of preparing giant plasma membrane vesicles (GPMVs) by using cysteine mutants of the proapoptotic peptide (PAP) Ac-R7-GG-KLAKLAKKLAKLAK. A cysteine scan revealed that cytotoxicity and GPMV formation were dependent on the cysteine position within the PAP sequence. In comparison to GPMVs prepared by extensive treatment with paraformaldehyde (PFA) and dithiothreitol (DTT), our GPMVs were produced from HeLa cells at much lower concentrations of the blebbing agent. We found that only GPMVs derived from cysteine-containing PAP showed lipid phase separation. This membrane model was applied to investigate the phase partitioning of two relevant membrane proteins: influenza virus hemagglutinin (HA) and tetherin, which clamps budding HIV to infected cells. For tetherin, we show for the first time exclusion from cholesterol-rich domains in a GPMV model, thus documenting the potential of our approach for membrane-partitioning studies.

Keywords: cysteine; giant vesicles; hemagglutinin; influenza virus; phase separation; tetherin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antigens, CD / metabolism
  • Cell Membrane / metabolism*
  • Cholesterol / metabolism
  • Cysteine / chemistry
  • Cysteine / metabolism*
  • GPI-Linked Proteins / metabolism
  • HeLa Cells
  • Hemagglutinin Glycoproteins, Influenza Virus / metabolism
  • Humans
  • Membrane Microdomains / metabolism*
  • Molecular Sequence Data
  • Orthomyxoviridae / physiology
  • Peptides / chemistry
  • Peptides / metabolism*
  • Phase Transition

Substances

  • Antigens, CD
  • BST2 protein, human
  • GPI-Linked Proteins
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Peptides
  • Cholesterol
  • Cysteine